Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Prof Kamlesh Khunti
-
MiFoot@uhl-tr.nhs.uk


Mrs Tolu Onuwe
+44 (0)756394005
tyo2@leicester.ac.uk


Dr Patrick Highton
-
MiFoot@uhl-tr.nhs.uk


More information about this study, what is involved and how to take part can be found on the study website.

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - MiFoot – reducing heart disease risk in those with a history of diabetic foot ulcers

MiFoot – reducing heart disease risk in those with a history of diabetic foot ulcers

Recruiting

Open to: All Genders

Age: Adult

Medical Conditions

Diabetes
Diabetes Foot Ulcer Disease (DFUD)


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


People with Type 2 diabetes and either a current or previous diabetes-related foot ulcer are often at high risk for future heart problems, such as heart attacks or strokes. This may be caused by different factors such as difficulty in being physically active, or managing their often complex condition. People might also find it more difficult to do every-day activities that are important to them, feel more anxious or depressed, and may need to use healthcare services more often. Healthcare for people with diabetes-related foot ulcers is usually focussed on treating the ulcer, and not preventing long-term heart problems.

What is MiFoot RCT?
The MiFoot RCT is a research study that will test a programme designed to improve heart health in people with diabetes and diabetes-related foot ulcers.
MiFoot programme aims to help people to better manage their condition, receive the most up to date care and be more physically active.
The MiFoot programme will include:
• Group-based education and exercise sessions
• One to one session with a health care professional
• An online platform designed to support patients to live a healthy lifestyle

We want to see whether the MiFoot programme can improve the health of people with current or previous diabetes-related foot ulcers, and if it is good value for money.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

01 Nov 2023 31 Aug 2026

Publications

2025 Protocol article in https://pubmed.ncbi.nlm.nih.gov/40186438/ (added 06/10/2025)

The study lasts 2 years, involves face-to-face visits to participants local hospital, the completion of questionnaires and the wearing of an activity monitor to measure your physical activity.


Adults over 18 years, with type 2 diabetes and current or previous diabetes-related foot ulcers.

You can take part if:


Current inclusion criteria as of 06/10/2025:

1. Males and Females aged >= 18 years
2. Diagnosed with T2D
3. Current or previous DFUD (defined as diagnosed with DFUD in the previous 5 years)
4. Ability to speak and read English or have a willing proxy who speaks and reads English
5. Participant is able (in the Investigators opinion) and willing to fulfil all the study requirements
6. Currently not taking part in a CTIMP or any other disease management or lifestyle-related intervention trial

At the baseline visit, physical activity screening will be undertaken to assess safety considerations as a precaution prior to physical activity as part of the intervention. The participant may be excluded from the physical activity part of the intervention, but not the remaining intervention elements. Participants with both vascular and neuropathic ulcers


You may not be able to take part if:


1. Diagnosed with other forms of diabetes (e.g., type 1 diabetes, monogenic diabetes (MODY), gestational diabetes or latent autoimmune diabetes in adults (LADA)2. Other, non-diabetic forms of ulceration (e.g., venous)3. Serious illness or event with life-expectancy < 1 year or other significant illness which, in the opinion of a study clinician, precludes involvement4. Planned major surgery5. Requirement for renal replacement therapy6. Current pregnancy, or actively trying to conceive7. Unwilling or unable to give informed consent to participate in the study 8. Current participation in a CTIMP or any other disease management or lifestyle-related intervention study (as determined by study investigator)9. Unable to understand or read English

Inability to participate in physical activity part of the intervention will not preclude inclusion in the study or the rest of the intervention, in order to represent the real-world situation. We will collect data concerning this as part of the process evaluation (section 5.2.2). The intervention will be delivered in English language and as such any participants who do not speak or read English to a sufficient standard will be excluded from the study. Every effort will be made to support participants with minimal English proficiency to participate.


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Royal Hallamshire Hospital
    Glossop Road
    Sheffield
    S10 2JF
  • Royal Free London NHS Foundation Trust
    Royal Free Hospital Pond Street
    London
    NW3 2QG
  • Glasgow Royal Infirmary
    84 Castle Street
    Glasgow
    G4 0SF
  • Northern Care Alliance NHS Foundation Trust
    Salford Royal Stott Lane
    Salford
    M6 8HD
  • Leicester General Hospital
    Gwendolen Road
    Leicester
    LE5 4PW
  • Epsom and St Helier University Hospitals NHS Trust
    St Helier Hospital Wrythe Lane
    Carshalton
    SM5 1AA
  • Florence Nightingale Community Hospital
    London Road
    Derby
    DE1 2QY
  • Mersey and West Lancashire Teaching Hospitals NHS Trust
    Whiston Hospital Warrington Road
    Prescot
    L35 5DR
  • Kings College Hospital, Renal Research Department
    Kings College Hospital Denmark Hill
    London
    SE5 9RS

Taking part in this research study could potentially benefit other people with diabetes and diabetes-related foot ulcers by providing information on how best to organise and deliver care in order to improve heart health and reduce the risk of future heart problems. This is important as there has not been much research in this area. The results could lead to improved medical treatments and care in the future.
Although there are many benefits of physical activity, it can pose some risks, however it is anticipated that these will be minimal. For example, you may experience delayed onset muscle soreness. Physical activity carried out as part of the MiFoot programme will be light-moderate, which can equate to walking upstairs or completing housework; therefore, your risk would not be increased over and above their usual day to day activities.

Mrs Tolu Onuwe
+44 (0)756394005
tyo2@leicester.ac.uk


Dr Patrick Highton
-
MiFoot@uhl-tr.nhs.uk


Prof Kamlesh Khunti
-
MiFoot@uhl-tr.nhs.uk



More information about this study, what is involved and how to take part can be found on the study website.


The study is sponsored by University of Leicester and funded by NIHR Central Commissioning Facility (CCF).





We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: ISRCTN13413505

Or CPMS 55056

Last updated 06 October 2025

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.